Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever-Reference-Cited by-同舟云学术

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever

Published:2015-11-03 Issue:6 Volume:213 Page:934-938
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Oestereich Lisa,Rieger Toni,Lüdtke Anja,Ruibal Paula,Wurr Stephanie,Pallasch Elisa,Bockholt Sabrina,Krasemann Susanne,Muñoz-Fontela César,Günther Stephan

Funder

Leibniz Center of Infection

European Commission

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/213/6/934/17411009/jiv522.pdf

Reference15 articles.

1. Lassa Fever

2. Molecular Diagnostics for Lassa Fever at Irrua Specialist Teaching Hospital, Nigeria: Lessons Learnt from Two Years of Laboratory Operation

3. Favipiravir (T-705), a novel viral RNA polymerase inhibitor

4. T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture

5. The search for synergy: a critical review from a response surface perspective;Greco;Pharmacol Rev,1995

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model;Antiviral Research;2024-11

2. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

3. Lassa Fever: Critical Review and Prospects for Control;Tropical Medicine and Infectious Disease;2024-08-14

4. Lassa fever research priorities: towards effective medical countermeasures by the end of the decade;The Lancet Infectious Diseases;2024-07

5. The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model;2024-05-15